NyasicosideCAS# 111518-94-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 111518-94-6 | SDF | Download SDF |
PubChem ID | 10648327 | Appearance | Powder |
Formula | C23H26O11 | M.Wt | 478.5 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R,3R,4S,5S,6R)-2-[(1R,2R)-1,5-bis(3,4-dihydroxyphenyl)-1-hydroxypent-4-yn-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | ||
SMILES | C1=CC(=C(C=C1C#CCC(C(C2=CC(=C(C=C2)O)O)O)OC3C(C(C(C(O3)CO)O)O)O)O)O | ||
Standard InChIKey | STEZVHWESYNLGU-XRWAXFQNSA-N | ||
Standard InChI | InChI=1S/C23H26O11/c24-10-18-20(30)21(31)22(32)23(34-18)33-17(19(29)12-5-7-14(26)16(28)9-12)3-1-2-11-4-6-13(25)15(27)8-11/h4-9,17-32H,3,10H2/t17-,18-,19-,20-,21+,22-,23-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Nyasicoside may have promising and beneficial thrombolytic activity. |
Nyasicoside Dilution Calculator
Nyasicoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0899 mL | 10.4493 mL | 20.8986 mL | 41.7973 mL | 52.2466 mL |
5 mM | 0.418 mL | 2.0899 mL | 4.1797 mL | 8.3595 mL | 10.4493 mL |
10 mM | 0.209 mL | 1.0449 mL | 2.0899 mL | 4.1797 mL | 5.2247 mL |
50 mM | 0.0418 mL | 0.209 mL | 0.418 mL | 0.8359 mL | 1.0449 mL |
100 mM | 0.0209 mL | 0.1045 mL | 0.209 mL | 0.418 mL | 0.5225 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Metformin HCl
Catalog No.:BCC4799
CAS No.:1115-70-4
- L-Cysteinesulfinic acid
Catalog No.:BCC6571
CAS No.:1115-65-7
- H-Ala-OEt.HCl
Catalog No.:BCC2687
CAS No.:1115-59-9
- Ac-DL-Met-OH
Catalog No.:BCC2999
CAS No.:1115-47-5
- 25-Anhydroalisol F
Catalog No.:BCN3361
CAS No.:1114895-01-0
- Amlodipine Besylate
Catalog No.:BCC4397
CAS No.:111470-99-6
- Naltrindole hydrochloride
Catalog No.:BCC6773
CAS No.:111469-81-9
- Axinysone B
Catalog No.:BCN7713
CAS No.:1114491-60-9
- Pinocembrin diacetate
Catalog No.:BCN5997
CAS No.:111441-88-4
- Azadirachtin
Catalog No.:BCC8123
CAS No.:11141-17-6
- Zileuton
Catalog No.:BCC2515
CAS No.:111406-87-2
- Lestaurtinib
Catalog No.:BCC2440
CAS No.:111358-88-4
- Nyasicol
Catalog No.:BCN5999
CAS No.:111518-95-7
- Fmoc-D-Phg-OH
Catalog No.:BCC3316
CAS No.:111524-95-9
- 3',5-Dihydroxy-4',5',6,7-tetramethoxyflavone
Catalog No.:BCN1620
CAS No.:111537-41-8
- Anonamine
Catalog No.:BCN2139
CAS No.:111566-66-6
- Cyanidin-3-O-arabinoside chloride
Catalog No.:BCN3023
CAS No.:111613-04-8
- GSK1838705A
Catalog No.:BCC3787
CAS No.:1116235-97-2
- Elastase Inhibitor
Catalog No.:BCC1225
CAS No.:111682-13-4
- Remacemide hydrochloride
Catalog No.:BCC7129
CAS No.:111686-79-4
- Demethoxyfumitremorgin C
Catalog No.:BCN7240
CAS No.:111768-16-2
- H-Glu-Oet.HCl
Catalog No.:BCC2685
CAS No.:1118-89-4
- (S)-(-)-HA-966
Catalog No.:BCC6589
CAS No.:111821-58-0
- 10-O-Methylprotosappanin B
Catalog No.:BCN6599
CAS No.:111830-77-4
Three novel constituents from curculigo capitulata and revision of C-2 stereochemistry in nyasicoside[Pubmed:10346957]
J Nat Prod. 1999 May;62(5):734-9.
Continuing study of the constituents of the rhizomes of Curculigo capitulata provided three novel compounds, including two norlignan glucosides, curcapicycloside (2) and (1S,2R)-O-methylNyasicoside (3), and a phenanthrofuran, curcapital (9). The former two compounds were characterized as their tetra-O-methyl derivatives. Compound 2 possesses a glucosyl-fused skeleton with 1R,2R configuration. Biogenetic consideration led to a revision of the previously assigned 2S configuration of Nyasicoside (1) to 2R, which was confirmed by NOE studies of the acetonide of its tetra-O-methyl derivative. The 2R configuration in tetra-O-methyl-1-O-methyl curculigine (7a) and isocurculigine (8a) was also established by chemical correlation of the former with (1R, 2R)-tetra-O-methyl-1-O-methylNyasicoside (10a). Curcapital (9) represents the first natural product having a phenanthro[9,10, b]furan skeleton.